Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2019
SIETES contiene 92806 citas

 
 
 1 a 20 de 207 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Ross JDC, Brittain C, Cole M, Dewsnap C, Harding J, Hepburn T, Jackson L, Keogh M, Lawrence T, Montgomery AA, Roberts TE, Sprange K, Tan W, Thandi S, Wilson J, Duley L, on behalf of the G-ToG trial team. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial. Lancet 2019:2 de mayo. [Ref.ID 103140]
2. Cita con resumen
Berghella V, Bellussi F. Antibiotics for operative vaginal delivery: practice-changing data. Lancet 2019;393:1. [Ref.ID 103123]
3.Enlace a cita original Cita con resumen
Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Hinshaw K, Tuffnell D, Linsell L, Juszczak E, on behalf of the ANODE collaborative group. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial. Lancet 2019;393:15 de junio. [Ref.ID 103118]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
White NJ. Tafenoquine - A radical improvement?. N Engl J Med 2019;380:17 de enero. [Ref.ID 103003]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Llanos-Cuentas A, Lacerda MVG, Hien TT, Vélez ID, Namaik-larp C, Chu CS, Villegas MF, Val F, Monteiro WM, Brito MAM, Costa MRF, Chuquiyauri R, Casapía M, Nguyen CH, Aruachan S, Papwijitsil R, Nosten FH, Bancone G, Angus B, Duparc S, Craig G, Rousell VM, Jones SW, Hardaker E, Clover DD, Kendall L, Mohamed K, Koh GCKW, Wilches VM, Breton JJ, Green JA. Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med 2019;380:17 de enero. [Ref.ID 103002]
6.Enlace a cita originalTiene citas relacionadas Cita con resumen
Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, Yilma D, Pereira DB, Espino FEJ, Mia RZ, Chuquiyauri R, Val F, Casapía M, Monteiro WM, Brito MAM, Costa MRF, Buathong N, Noedl H, Diro E, Getie S, Wubie KM, Abdissa A, Zeynudin A, Abebe C, Tada MS, Brand F, Beck H-P, Angus B, Duparc S, Kleim J-P, Kellam LM, Rousell VM, Jones SW, Hardaker E, Mohamed K, Clover DD, Fletcher K, Breton JJ, Ugwuegbulam CO, Green JA, Koh GCKW. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med 2019;380:17 de enero. [Ref.ID 103001]
7.Enlace a cita original Cita con resumen
Taylor SN, Marrazzo J, Batteiger BE, Hook III EW, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, Mueller J. Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea. N Engl J Med 2018;379:8 de noviembre. [Ref.ID 102865]
8. Cita con resumen
Geisler WM, Uniyal A, Lee JY, Lensing SY, Johnson S, Perry RCW, Kadrnka CM, Kerndt PR. Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection. N Engl J Med 2015;373:2512-21. [Ref.ID 99766]
9.Enlace a cita original
Donnerstag N, Schneider TH, Lüthi A, Taeqtmeyer A, Raetz Bravo A, Mehliq A. Severe opioid withdrawal syndrome after a single dose of nalmefene. Eur J Clin Pharmacol 2015;71:1025-6. [Ref.ID 99382]
10. Cita con resumen
Greenspan SL, Perera S, Ferchak MA, Nace DA, Resnick M. Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. JAMA Intern Med 2015;175:913-21. [Ref.ID 99183]
11. Cita con resumen
Anónimo. Misoprostol: des accidents cardiovasculaires graves, même après une seule prise. Prescrire 2015;35:108-10. [Ref.ID 98919]
12.Enlace a cita original
Klumpers LE, Roy C, Ferron G, Turpault S, Poitiers F, Pinquier J-L, van Hasselt JGC, Zuurman L, Erwich FAS, van Gerven JMA. Surinabant, a selective cannabinoid receptor type 1 antagonists, inhibitis delta-9-tetrahydrocannabinol-induced central nervous systsem and heart rate effects in humans. Br J Clin Pharmacol 2013;76:65-77. [Ref.ID 95803]
13.Enlace a cita original
Frost C, Wang J, Nepal S, Schuster A, Barrett YC, Mosqueda-García R, Reeves RA, LaCreta F. Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects. Br J Clin Pharmacol 2013;75:476-87. [Ref.ID 94856]
15.Tiene citas relacionadas Cita con resumen
Li GL, Winter H, Arends R, Jay GW, Le V, Young T, Huggins JP. Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects. Br J Clin Pharmacol 2012;73:706-16. [Ref.ID 92795]
16. Cita con resumen
Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosier P, Higgins PDR, Hayward RA, Romagnuolo J, Elta GH, Sherman S, Waljee AK, Repaka A, Atkinson MR, Cote GA, Kwon RS, McHenry L, Piraka CR, Wamsteker EJ, Watkins JL, Korsnes SJ, Schmidt SE, Turner SM, Nicholson S, Fogel EL, for the U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366:1414-22. [Ref.ID 92751]
19.Tiene citas relacionadas
Ponder KP. Merry Christmas for patients with hemophilia B. N Engl J Med 2011;365:2426-31. [Ref.ID 91983]
20.Tiene citas relacionadas Cita con resumen
Nathwani AC, Tuddenham EGD, Rangarajan S, Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C, O'Beirne J, Smith K, Pasi J, Glader B, Rustagi P, Ng CYC, Kay MA, Zhou J, Spence Y, Morton CL, Allay J, Coleman J, Sleep S, Curringham JM, Srivastava D, Basner-Tschakarjan EB, Mingozzi F, High KA, Gray JT, Reiss UM, Nenhuis AW, Davidoff AM. Adenovirus-associated virus vector - Mediated gene transfer in hemophilia B. N Engl J Med 2011;365:2357-65. [Ref.ID 91981]
Seleccionar todas
 
 1 a 20 de 207 siguiente >>